Bonesupport Holding AB (publ) (LON:0RQO)

Market Cap	995.86M -44.0%
Revenue (ttm)	88.36M +37.4%
Net Income	11.99M +67.7%
EPS	0.18 +65.6%
Shares Out	n/a
PE Ratio	83.03
Forward PE	42.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,315
Average Volume	51,951
Open	181.00
Previous Close	184.95
Day's Range	179.60 - 181.00
52-Week Range	176.00 - 401.60
Beta	0.43
RSI	44.54
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 143
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RQO

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.

Financial numbers in SEK